-
Diagnostics World | A team of Iraqi and Australian researchers from Middle Technical University (MTU) in Baghdad, Iraq, and the University of South Australia (UniSA) collaborated to develop an AI model that can predict diseases based on the color of the patient’s tongue.
Sep 10, 2024
-
Diagnostics World | It now appears possible to develop a series of blood-based tests looking for the “sparse” protein signatures of 67 pathologically diverse diseases, which would enable the early detection of high-risk individuals in primary care settings who could then be closely monitored for development of those conditions.
Sep 5, 2024
-
Diagnostics World | Today, Proscia announced a real-world data offering on its Concentriq platform comprising a diverse repository of over 10 million whole slide images enhanced with structured data from molecular tests, pathology reports, laboratory tests, and next-generation sequencing across therapeutic areas.
Sep 4, 2024
-
Diagnostics World | Courtney Lias, Ph.D., the newly named director of the FDA’s Office of In Vitro Diagnostic Devices (OHT7) took to the stage at last week’s Next Generation Dx Summit to discuss the latest trends, and associated challenges, in carrying out total product lifecycle activities for in vitro diagnostic devices for the Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH).
Sep 3, 2024
-
Diagnostics World | Third Arc Bio plans to use their funding to address unmet needs in oncology and autoimmunity; Foresight Diagnostics plans to accelerate the clinical development and commercialization of their cancer recurrence testing platform, PhasED-Seq, which leverages the sequencing of phased variants for ultrasensitive and highly specific detection of circulating tumor DNA (ctDNA); and more.
Aug 29, 2024
-
Diagnostics World | Roche announced the completion of the acquisition of LumiraDx’s Point of Care technology; NOWDiagnostics announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know Syphilis Test for OTC use; MAUI Imaging emerged from stealth with the announcement of a $4 million U.S. Department of Defense (U.S. Army Medical Research and Development Command) contract to support trauma medicine across four branches of the military seeking to enable faster diagnosis and interventional care; and more.
Aug 28, 2024
-
Diagnostics World | A final rule on laboratory-developed tests (LDTs) released by the U.S. Food and Drug Administration (FDA) in early May has done little to settle the longstanding debate about how LDTs ought to be regulated. The rule clarifies that in vitro diagnostic products (IVDs) are medical devices under the Federal Food, Drug, and Cosmetic Act, even when the manufacturer is a laboratory, and establishes a framework for FDA oversight of LDTs inclusive of a policy to phase out the agency's "enforcement discretion" policy.
Aug 26, 2024
-
Diagnostics World | For clinical laboratories, keeping up with the changing landscape of carrier screening has been quite challenging lately. A maze of ancestry-based screening guidelines has been replaced with new guidelines that call for screening an order of magnitude of more genes.
Aug 23, 2024
-
Diagnostics World | Theranos comparisons are generally not favorable, but Babson Diagnostics has now rolled out blood testing that achieves what Theranos claimed to: needle-free, small-volume blood testing, from the convenience of retail pharmacies.
Aug 21, 2024
-
Diagnostics World | New technology, powered by artificial intelligence (AI), aims to bring breast and ovarian cancer patients the expected value of genomic sequencing—a more precise diagnosis and personalized treatment strategy—potentially without ever having their DNA analyzed.
Aug 20, 2024
-
Diagnostics World | Last week, Paige, in collaboration with Microsoft, unveiled the second generation of Virchow, its million-slide foundation model for cancer. Virchow2 and Virchow2G offer a deeper understanding of cells and tissue, aiming to redefine cancer diagnosis and treatment.
Aug 16, 2024
-
Diagnostics World | In recent months, Diagnostics World has taken a look at new developments taking place in the field of sarcoidosis research, including progress made toward a simple blood test and new treatment options as well as efforts to gain a better understanding of cardiac sarcoidosis in particular. Here, we explore the role of philanthropic funding, highlight research projects and collaborative initiatives, and sum up efforts to improve clinical trial diversity.
Aug 15, 2024
-
Diagnostics World | Researchers at The Australian National University (ANU) have developed a deep learning algorithm, known as DEPLOY, to classify central nervous system tumors into 10 major categories from histopathology images. The goal is to optimize treatment with a faster, more accessible diagnostic approach than the state-of-the-art practice of DNA methylation-based profiling, which can take weeks.
Aug 13, 2024
-
Diagnostics World | Obstructive sleep apnea (OSA) is a sleep disorder associated with major cardiovascular complications. Despite being a common sleep disorder, there has not been an effective drug treatment for patients. Fortunately, a team from the University of California San Diego School of Medicine recently published a drug repurposing study that may offer hope.
Aug 8, 2024
-
Diagnostics World | Companion diagnostics (CDx) have revolutionized the treatment of cancer by helping to improve the safety and tolerability of targeted drugs—a key feature of precision medicine. The U.S. Food and Drug Administration (FDA) has to date approved nearly 180 CDx, many for rare diseases but only four of those outside of oncology.
Aug 7, 2024
-
Diagnostics World | GE HealthCare and Amazon Web Services have announced a strategic collaboration to develop purpose-built foundation models and generative artificial intelligence (AI) applications designed to help clinicians improve medical diagnostics and patient care.
Aug 6, 2024
-
Diagnostics World | Evidence is mounting that public health in the U.S. could get a big boost by better engaging community pharmacists in providing acute and chronic care services. These are highly trained clinicians in “extremely accessible” locations no more than five miles from the home of 95% of Americans.
Aug 1, 2024
-
Diagnostics World | A study published in JAMA yesterday suggests blood tests can more accurately detect Alzheimer’s disease than physicians, and points to a way forward for more extensive Alzheimer’s testing. More blood testing developments are on display at this week's Alzheimer’s Association International Conference.
Jul 29, 2024
-
Diagnostics World | Researchers at The Australian National University (ANU) have developed a deep learning algorithm, known as DEPLOY, to classify central nervous system tumors into 10 major categories from histopathology images. The goal is to optimize treatment with a faster, more accessible diagnostic approach than the state-of-the-art practice of DNA methylation-based profiling, which can take weeks.
Jul 25, 2024
-
Diagnostics World | Element Biosciences nets $277 million to launch combined sequencing and cyto-profiling platform; NOWDiagnostics raises $22.5 million for at-home diagnostic tests; and more.
Jul 24, 2024